Clinical Trial Update: A Study Evaluating the Safety of VX-152 Combination Therapy in Adults With Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety of VX-152 combination therapy in adults with cystic fibrosis has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• VX-152

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2021-01-28